EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY 4.0

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis

Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal iD, Zhi-Qi Wu, Jie-Xin Zhang iD, Hua-Guo Xu iD

Journal of Clinical Medicine · 02.02.2023 · 12 (3) · 1206

DOI: 10.3390/jcm12031206 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.02.2023. Verfasst von Jin-Tong Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province of China, National Key Clinical Department of Laboratory Medicine of China in Nanjing, Key Laboratory for Laboratory Medicine of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fecal calprotectin (FC) levels correlate with the disease activity of inflammatory bowel diseases (IBD); however, the utility of FC in predicting IBD relapse remains to be determined. We aim to evaluate the efficacy of fecal calprotectin in predicting the relapse of inflammatory bowel disease. We searched Pubmed (MEDLINE), Embase, Web of Science, and the Cochrane library databases up to 7 July 2021. Our study estimated the pooled sensitivity and specificity, summary receiver operating characteristic (SROC) curve, and the optimal cut-off value for predicting IBD relapse using a multiple threshold model. A total of 24 prospective studies were included in the meta-analysis. The optimal FC cut-off value was 152 μg/g. The pooled sensitivity and specificity of FC was 0.720 (0.528 to 0.856) and 0.740 (0.618 to 0.834), respectively. FC is a useful, non-invasive, and inexpensive biomarker for the early prediction of IBD relapse. An FC value of 152 μg/g is an ideal threshold to identify patients with a high relapse probability.

Schlagwörter

Stichwörter der Autor:innen

Fecal calprotectinbiomarkerdiagnosisinflammatory bowel diseases

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Division of Gastroenterology, Hepatology & Nutrition, University of Texas Health Sciences Center, Houston, TX 77030, USA.

ORCID-Profile: Hemant Goyal, Jie-Xin Zhang, Hua-Guo Xu

Förderung

  • Natural Science Foundation of Jiangsu Province of China
  • National Key Clinical Department of Laboratory Medicine of China in Nanjing
  • Key Laboratory for Laboratory Medicine of Jiangsu Province
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Shi, J. T., Chen, N., Xu, J., Goyal, H., Wu, Z. Q., Zhang, J. X., & Xu, H. G. (2023). Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine, 12(3), 1206. https://doi.org/10.3390/jcm12031206

Vancouver

Shi JT, Chen N, Xu J, Goyal H, Wu ZQ, Zhang JX, et al. Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine. 2023;12(3):1206. doi:10.3390/jcm12031206

BibTeX
@article{Shi2023,
  author = {Shi, Jin-Tong and Chen, Nuo and Xu, Jia and Goyal, Hemant and Wu, Zhi-Qi and Zhang, Jie-Xin and Xu, Hua-Guo},
  title = {Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {1206},
  doi = {10.3390/jcm12031206}
}
Kostenlos starten →